{"metadata":{"topics":["Abuse","Accountability","Administrative law","Applied ethics","Artificial objects","Attorney's fee","Bloomberg L.P.","Business","Business law","Business organizations","Capital (economics)","Cash","Certificate of incorporation","Choice of law","Civil law (common law)","Civil law (legal system)","Common law","Common stock","Communication","Companies","Company","Comparative law","Concealed carry in the United States","Conflict (process)","Conflict of laws","Consent","Constitutional law","Contract law","Convertible","Corporate finance","Corporate governance","Corporate law","Corporate personhood","Corporation","Corporations","Corporatism","Court","Courts","Covenant (law)","Criminal justice","Criminal law","Cultural globalization","Culture","Custom","Damages","Delaware","Derivatives (finance)","Doctrines","Document","Documents","Economic law","Economics","Economies","Economy","Economy of Europe","Economy of the United States","Email","Equity (finance)","Equity securities","Ethical principles","Ethics","Eucalyptus","Executive branch of the United States government","Exercise","Fax","Federal judiciary of the United States","Finance","Financial accounting","Financial economics","Financial law","Financial markets","Financial regulation","Financial services","Formula","Government","Government agencies","Government and personhood","Government information","Government institutions","Government of the United States","Government-related organizations","Hedge","Hedge fund","Human activities","Human rights","Incentive","Indemnity","Intellectual works","International law","International relations","Investment","Investor","Judiciaries","Jurisdiction","Jurisprudence","Jury","Jury trial","Justice","LP record","Law","Law and economics","Law of obligations","Lawsuits","Lawyer","Legal action","Legal concepts","Legal disputes","Legal doctrines and principles","Legal documents","Legal ethics","Legal fictions","Legal organizations","Legal procedure","Legal writing","Limited liability company","Limited partnership","Liquidated damages","Liquidation","Love","Management","Manhattan","Market (economics)","Matter","Microeconomics","Money","Morality","Naked short selling","New York (state)","New York City","OTC Bulletin Board","Official documents","Open government","PDF","Paper","Par value","Percentage","Personal computer","Personality traits","Political charters","Political economy","Political science","Politics","Politics of the United States","Practice of law","Preferred stock","Price","Principles","Private law","Professional ethics","Property","Property law","Public administration","Public law","Public policy","Public records","Public sphere","Regulation","Rights","Roman law","Rule of law","Rules","Sales","Securities (finance)","Securities Act of 1933","Securities Exchange Act of 1934","Security (finance)","Separation of powers","Service industries","Services (economics)","Share (finance)","Shareholder","Short (finance)","Signature","Social institutions","Social issues","Sociological theories","Sources","Sources of law","State court (United States)","Statute","Statutory law","Stock","Stock market","Theories of law","Trial","U.S. Securities and Exchange Commission","U.S. state","UBS","Understanding","United States","United States dollar","United States economic policy","United States federal law","United States federal policy","United States law","United States legislation","United States public law","Value (ethics)","Venture round","Virtue","Waiver","Warrant (finance)","Weighted arithmetic mean","Witness","Written communication"],"person_names":["counterpart","holder","mitchell d. kaye"],"vars":{},"organization_names":["bloomberg lp","caduceus capital master fund","commission","europa international inc.","europa international, inc.","exhibit a","ii master fund ltd.","knoll capital management","longview fund","longview fund lp","ltd.","novelos therapeutics, inc.","orbimed advisors","rosebay medical company","ubs","xmark","xmark jv investment","xmark opportunity fund"],"agreement_id":"775c4075f36154a8204558e01e7c7d74a795564394274a2325f9cfd030a2aebf","terms":["* Pc) / (Px *","**(included as  to this filing)**","**Authorized Shares**","**BEACON COMPANY**","**CADUCEUS CAPITAL II, L.P.**","**CADUCEUS CAPITAL MASTER FUND**","**Choice of Law**","**Consent and Waiver of Series C Holders**","**Consent of Series E Holders**","**Counterparts**","**EQUITY FUND, LP**","**EUROPA INTERNATIONAL, INC.**","**EXHIBIT A**","**Entire Agreement**","**Exhibit A**","**FORM OF WARRANT**","**FUND II MASTER FUND LTD.**","**HEDGE FUND INVESTORS LLC**","**Incentive Warrants**","**KNOLL SPECIAL OPPORTUNITIES**","**LIMITED**","**LONGVIEW EQUITY FUND, LP**","**LONGVIEW FUND, LP**","**LONGVIEW INTERNATIONAL**","**NOVELOS THERAPEUTICS, INC.**","**OF HOLDERS OF SERIES C CONVERTIBLE PREFERRED STOCK AND**","**OF NOVELOS THERAPEUTICS, INC.**","**PARTNERS**","**PW EUCALYPTUS FUND, LTD.**","**ROSEBAY MEDICAL COMPANY, L.P.**","**Registration Rights**","**SERIES C HOLDERS:**","**SERIES E CONVERTIBLE PREFERRED STOCK**","**SERIES E HOLDERS:**","**SUMMER STREET LIFE SCIENCES**","**UBS EUCALYPTUS FUND, L.L.C.**","**WRITTEN CONSENT AND WAIVER**","**XMARK JV INVESTMENT**","**XMARK OPPORTUNITY FUND, L.P.**","**XMARK OPPORTUNITY FUND, LTD.**","**“No-Short.”**","“Amendment”","“Commission”","“Common Stock”","“Corporation”","“Rule 144”","“Series C Certificate of Designations”","“Series C Holders” and, together with the Series E Holders, the “Holders”","“Series C Preferred Stock”","“Series E Certificate of Designations”","“Series E Holders”","“Series E Preferred Stock”","“Transaction”","“Warrants”","“pdf”"]}}